MNKD Q2 2020 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$841M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15M+0.7% YoY

Gross Profit

$9M62.6% margin

Operating Income

-$8M-52.4% margin

Net Income

-$10M-67.8% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

-6.9%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$103M

Total Liabilities

$282M

Stockholders' Equity

-$180M

Cash & Equivalents

$63M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$15M	+0.7%
Gross Profit	$9M	$9M	+10.8%
Operating Income	-$8M	-$11M	+27.7%
Net Income	-$10M	-$12M	+17.2%

Revenue Segments

Product

$7M100%